淋巴管新生
淋巴系统
淋巴管内皮
血管内皮生长因子C
平足蛋白
生物
淋巴水肿
癌症研究
淋巴管
细胞生物学
内皮干细胞
病理
免疫学
医学
转移
血管内皮生长因子
癌症
血管内皮生长因子A
血管内皮生长因子受体
遗传学
乳腺癌
体外
作者
Seiji Kato,Hiroshi Shimoda,Rui‐Cheng Ji,Masahiro Miura
出处
期刊:Kaibogaku Zasshi
日期:2006-06-01
卷期号:81 (2): 71-83
被引量:65
标识
DOI:10.1111/j.1447-073x.2006.00142.x
摘要
In recent years, several functional molecules specifically expressed and localized in lymphatic endothelial cells, such as 5’-nucleotidase, lymphatic vessel endothelial receptor-1, vascular endothelial growth factor receptor-3, podoplanin and Prox-1, have been identified. The discovery of the lymphatic endothelial cell markers facilitated detailed analysis of the nature and structural organization of the lymphatic vessels and their growth (lymphangiogenesis). As a result, over the past few years, advances have been made in understanding the cellular and molecular aspects of physiological lymphangiogenesis and tumor-induced lymphangiogenesis. The biology of lymphangiogenesis, particularly the mechanism of its regulation, is very important in understanding the formation of the lymphatic system as a biological regulation system transporting tissue fluid and wandering cells, including lymphocytes, and disease involving lymphangiogenesis. The understanding of the molecular mechanism of lymphangiogenesis and the elucidation of the development of normal and pathological tissues are expected to lead to the development of therapy for intractable diseases, such as malignant tumors and lymphedema.
科研通智能强力驱动
Strongly Powered by AbleSci AI